Literature DB >> 18022893

Preliminary study into the economic burden of Down syndrome in China.

Yingyao Chen1, Xu Qian, Jie Zhang, Jun Li, Annie Chu, Stuart O Schweitzer.   

Abstract

BACKGROUND: To measure the economic burden of Down syndrome (DS) in China is to facilitate strategic planning development for managing and preventing DS.
METHODS: The economic burden of DS was calculated from direct healthcare costs, direct non-health-care costs, and indirect costs. The incidence approach was employed to measure the lifetime economic burden of a new DS birth in China in 2003. Most parameters came from a household health services survey, which was given to caregivers of people with DS. This survey was conducted in Hebei, Shaanxi, and Shanghai in 2004.
RESULTS: Caregivers of 222 people with DS were interviewed in six cities and neighboring rural areas. Average expenses and utilization rate of different services by age groups from this sample were obtained to estimate the economic burden of DS. The average lifetime economic burden of a new DS case from the family perspective and the societal perspective amounted to US$47,000 and US$55,000, respectively. Indirect (productivity) costs were responsible for most of the total economic loss. Sensitivity analysis showed that the incidence rate, survival rate, value of productivity such as GDP per capita or salary, productivity of people with DS, and utilization rate of related services were influencing factors to the economic burden of DS.
CONCLUSIONS: The economic burden of DS is substantial for the family of a person with DS, as well as to society. Appropriate management and prevention of DS is needed to reduce the heavy burden for people with DS and their families. Birth Defects Research (Part A) 2008. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18022893     DOI: 10.1002/bdra.20409

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  The unforeseen toll of birth defects and their economic burden at a tertiary care public institute in Mumbai.

Authors:  Mamta Muranjan; P Vijayalakshmi
Journal:  Indian J Pediatr       Date:  2014-04-26       Impact factor: 1.967

2.  A Retrospective Analysis Of Different Contingent Screening Models For Fetal Down Syndrome In Southwestern China.

Authors:  Wei Luo; Bin He; Daiwen Han; Lixing Yuan; Xinlian Chen; Ling Pang; Jun Tang; Fene Zou; Kai Zhao; Yepei Du; Hongqian Liu
Journal:  Sci Rep       Date:  2020-06-11       Impact factor: 4.379

3.  Psychometric Assessment of the Mandarin Version of the Decisional Conflict Scale with Pregnant Women Making Prenatal Test Decisions.

Authors:  Jia-Ming Xiang; Ke Sun; Qian Zhao; Han-Bing Li; Ling-Ling Gao
Journal:  Patient Prefer Adherence       Date:  2022-01-18       Impact factor: 2.711

4.  Incidence of Down Syndrome by maternal age in Chinese population.

Authors:  Yi Song; Song Jieping; Zhou Tianshu; Zhang Zhijun; Zhang Jingxuan; Wang Bo
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

5.  Who Should Be Targeted for the Prevention of Birth Defects? A Latent Class Analysis Based on a Large, Population-Based, Cross-Sectional Study in Shaanxi Province, Western China.

Authors:  Zhonghai Zhu; Yue Cheng; Wenfang Yang; Danyang Li; Xue Yang; Danli Liu; Min Zhang; Hong Yan; Lingxia Zeng
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

6.  Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study.

Authors:  Chuanlin Li; Leiyu Shi; Jiayan Huang; Xu Qian; Yingyao Chen
Journal:  BMC Health Serv Res       Date:  2016-01-14       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.